Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study | Neolys Diagnostics

fr

en

Qui sommes-nous

Notre technologie

English version

Accueil

Publications & brevets

Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study

Actus